Clinical Trials
RESP® Biosensor
Capture accurate, objective cough and lung sound metrics, driving stronger evidence in respiratory drug development
FDA 510(k) Class II Device | CE Mark | HIPAA Compliant
Symptoms such as cough, wheeze, and crackles are common across several cardiopulmonary and infectious diseases. Patient self-reports, while valuable, may not fully capture the objective reality these symptoms present. The RESP® Biosensor detects the full scope of respiratory symptoms and other insights, providing stronger, quantitative evidence to demonstrate treatment efficacy.
The Next Generation Cough Monitoring Device
Unlock 24-hour clinically accurate and continuous monitoring of cough and lung sounds with the RESP® Biosensor. Optimized for ease of use at home as part of clinical trials, our cough monitoring device offers:
- Enhanced Patient Compliance: A wireless, discreet design that respects patient comfort and lifestyle.
- Rapid, Reliable Data Access: Direct cloud sync facilitates efficient analysis of objective respiratory metrics.
- Superior and Comprehensive Data: Captures detailed cough and lung sound data, offering insights beyond traditional methods.
RESP® Biosensor Measures
Cough Monitoring
24-Hour Cough Frequency, Intensity* and Bouts
Lung Sounds
Additional Insights*
*For investigational use only
Why Choose the RESP® Biosensor for Cough Monitoring?
Privacy & Security
Accelerated Insights
Subject Cough Only
Multi-modal data are used to differentiate between subject coughs and external coughs.
Patient Friendly
Granular Metrics
Extended measurements beyond cough frequency allow for a greater understanding of lung health and subject quality of life.
Metrics-at-a-Glance
600k+
19m+
4
35
2
1
Clinical Trial Therapeutic Areas
Using a combination of audio and motion data, the RESP Biosensor unlocks valuable insight across multiple indications, offering a more complete picture of subjects’ respiratory status and health-related quality of life.
Cough | Wheeze | Crackles | Respiratory Rate* | Activity Levels* | Sleep/Wake* | Body Positioning* | |
Chronic Cough | |||||||
IPF | |||||||
Bronchitis | |||||||
COPD | |||||||
Asthma | |||||||
RSV | |||||||
Covid-19 | |||||||
Heart Failure |
- Chronic Cough
- IPF
- Bronchitis
- COPD
- Asthma
- RSV
- Covid-19
- Heart Failure
*For investigational use only
Cough Monitoring Designed for Daily Life
- Compared to bulkier alternatives, the RESP Biosensor
reduces subject and site burden. - Wireless and discreet, subjects report that they forget the cough monitoring device is on.
- Sleek design helps ensure patients behave naturally,
capturing authentic symptom data that mirrors real-life
conditions.
Expert Overread Process
- Our team of trained respiratory therapists and labelers review subject lung sound recordings to meet regulatory and clinical requirements for data accuracy.
- Machine learning algorithms* have been trained based on validated cough and lung sound events and performance tested to meet customer requirements.
- Algorithms* can be used independently or to assist in the overread process.
**Machine learning algorithms not FDA-cleared
Lung sound recordings are depicted as spectrograms to facilitate overread